The Prognostic Value of Time in Range in Type 2 Diabetes

被引：3
|
作者：
Selvin, Elizabeth [1 ]
机构：
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
来源：
DIABETES CARE | 2021年 / 44卷 / 02期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.2337/dci20-0066
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：319 / 320
页数：2
相关论文
共 50 条
  • [41] Inhaled Insulin Improves Daytime Time-in-Range in People with Type 2 Diabetes
    Desborough, Lane
    Levin, Philip
    Bromberger, Lee A.
    DIABETES, 2021, 70
  • [42] Effects of dulaglutide combined with insulin degludec on time in range in type 2 diabetes mellitus
    黄金鑫
    China Medical Abstracts(Internal Medicine), 2023, 40 (01) : 25 - 25
  • [43] Association of Time in Range with Endothelial Injury in Patients with Type 2 Diabetes Treated with Exenatide
    Yunyi Le
    Kun Yang
    Jin Yang
    Wei Fu
    Wenhua Xiao
    Rui Wei
    Tianpei Hong
    Diabetes Therapy, 2022, 13 : 1755 - 1767
  • [44] IDegLira improves time in range in a cohort of patients with type 2 diabetes: TiREX study
    Malighetti, Maria Elena
    Molteni, Laura
    Orsi, Emanuela
    Serra, Roberta
    Gaglio, Alessia
    Mazzoleni, Federica
    Russo, Filomena
    Bossi, Antonio Carlo
    ACTA DIABETOLOGICA, 2024, : 367 - 374
  • [45] Association of Time in Range with Endothelial Injury in Patients with Type 2 Diabetes Treated with Exenatide
    Le, Yunyi
    Yang, Kun
    Yang, Jin
    Fu, Wei
    Xiao, Wenhua
    Wei, Rui
    Hong, Tianpei
    DIABETES THERAPY, 2022, 13 (10) : 1755 - 1767
  • [46] Is there a target value for time in tight range for individuals with type 1 diabetes on MDI? Data from masked CGM
    Ohno, Takayuki
    Tsujino, Daisuke
    Nishimura, Rimei
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2024, 19 (06) : 507 - 512
  • [47] Correlation between mild cognitive impairment and time in range,time below and above the target range in patients with type 2 diabetes mellitus
    迟海燕
    ChinaMedicalAbstracts(InternalMedicine), 2023, 40 (03) : 152 - 153
  • [48] Time above range and not time below range is associated with mortality in older patients with type 2 diabetes: results from the HYPOAGE study
    Smati, S.
    Boureau, A. -S.
    Guyomarch, B.
    Allix, I.
    Annweiler, C.
    Cervantes, N.
    Delabriere, I.
    Gourdy, P.
    Guyonnet, S.
    Litke, R.
    Paccalin, M.
    Penfornis, A.
    Saulnier, P. -J.
    Hadjadj, S.
    Cariou, B.
    DIABETOLOGIA, 2024, 67 : S103 - S104
  • [49] RCT EVIDENCE ON TIME-IN-RANGE IN TYPE 1 DIABETES
    Battelino, T.
    Danne, T.
    Edelman, S.
    Choudhary, P.
    Renard, E.
    Westerbacka, J.
    Mukherjee, B.
    Picard, P.
    Pilorget, V.
    Bergenstal, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A11 - A12
  • [50] TIME IN RANGE IN CHILDREN WITH TYPE 1 DIABETES IN A PEDIATRIC UNIT
    Silva, L.
    Belinha, F.
    Serra Caetano, J.
    Cardoso, R.
    Dinis, I.
    Mirante, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A175 - A175
12345